InnoCare Pharma Inc.
CIK: 0002089568
Transaction Breakdown
Open Market Buys (P)0
High conviction signal
Open Market Sales (S)0
Position reduction
Option Exercises (M)0
Derivative conversions
Awards (A)0
Compensation grants
Other (G, F, J, C, D, …)0
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ZBIO
Zenas BioPharma, Inc.
10% Owner
Discretionary Trading P&L
Holdings
Transaction History (0 total)
2 Form 3 filings on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024.
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| 2 Form 3 filings on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024. | ||||||
0-0 of 0 transactions
About InnoCare Pharma Inc.
InnoCare Pharma Inc. (SEC CIK 0002089568) files insider reports with the SEC as 10% Owner of Zenas BioPharma, Inc. (ZBIO).
Signal8 holds 2 ownership filings by InnoCare Pharma Inc., all Form 3s, filed between Oct 15, 2025 and Sep 8, 2026. A Form 3 is an initial statement of ownership: it reports holdings, not trades, so no Form 4 or Form 5 transactions are on record since Sep 2024.
The business address on InnoCare Pharma Inc.'s filings is in PRINCETON, NJ.
Other insiders filing for Zenas BioPharma, Inc. (ZBIO)
- Oliger Christy J., Director
- Nunn Jason Raleigh, Director
- Lu Hongbo, Director
- MOULDER LEON O JR
- ORLOFF JOHN J, Director
- von Moltke Lisa